retatrutide side effects effects: what the trials show and how to manage them Retatrutide side effects: GI, heart,

And the risks of untreated obesitydiabetes, heart disease, cancerare far more dangerous

DAlessio et al

Table of Contents Understanding Nausea with GLP-1 Receptor Agonists GLP-1 receptor agonists cause nausea primarily by slowing gastric emptying, an effect that is most pronounced during treatment initiation and dose escalation

New research published in JACC , the flagship journal of the American College of Cardiology, and presented just last month at the 2024 American Heart Association Scientific Sessions revealed that GLP-1 drugs, including semaglutide, offer cardiovascular benefits beyond weight loss

At 12 mg, the trajectory suggests sustained loss well beyond the point where tirzepatide users at 15 mg have already plateaued

Adequate protein intake, hydration, and nutrient-dense foods support both milk production and weight loss, though weight loss rates may be slower than with medication